TG Therapeutics, Inc. (TGTX)
53.87
-1.52
(-2.74%)
USD |
NASDAQ |
Sep 11, 16:00
53.87
0.00 (0.00%)
After-Hours: 16:27
TG Therapeutics Gross Profit (TTM) : 658.60M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 658.60M |
| March 31, 2026 | 581.67M |
| December 31, 2025 | 515.52M |
| September 30, 2025 | 453.81M |
| June 30, 2025 | 394.67M |
| March 31, 2025 | 337.55M |
| December 31, 2024 | 290.24M |
| September 30, 2024 | 233.54M |
| June 30, 2024 | 321.25M |
| March 31, 2024 | 270.23M |
| December 31, 2023 | 219.11M |
| September 30, 2023 | 183.03M |
| June 30, 2023 | 20.82M |
| March 31, 2023 | 7.179M |
| December 31, 2022 | 2.133M |
| September 30, 2022 | 4.293M |
| June 30, 2022 | 6.068M |
| March 31, 2022 | 7.025M |
| December 31, 2021 | 5.90M |
| September 30, 2021 | 3.721M |
| June 30, 2021 | 1.927M |
| March 31, 2021 | 0.478M |
| December 31, 2020 | -2.223M |
| September 30, 2020 | -2.19M |
| June 30, 2020 | -2.122M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.055M |
| December 31, 2019 | 0.007M |
| September 30, 2019 | 0.056M |
| June 30, 2019 | 0.059M |
| March 31, 2019 | 0.061M |
| December 31, 2018 | 0.064M |
| September 30, 2018 | 0.0677M |
| June 30, 2018 | 0.0699M |
| March 31, 2018 | 0.0699M |
| December 31, 2017 | 0.0699M |
| September 30, 2017 | 0.0698M |
| June 30, 2017 | 0.0716M |
| March 31, 2017 | 0.0757M |
| December 31, 2016 | 0.0894M |
| September 30, 2016 | 0.0718M |
| June 30, 2016 | 0.0529M |
| March 31, 2016 | 0.0317M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Krystal Biotech, Inc. | 411.03M |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| BioMarin Pharmaceutical, Inc. | 2.556B |
| Cytokinetics, Inc. | 46.98M |
| Exelixis, Inc. | 2.350B |